Publications

The structural basis for LRRK2’s activation and autoinhibition

 2043
The structural basis for LRRK2’s activation and autoinhibition

Tags:

Previous Article

Brain-to-liver pathway that protects against liver inflammation

Next Article

How Parkinson's protein is activated?

Related Posts

Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent Treg–microglia crosstalk

Nasal anti-CD3 monoclonal antibody ameliorates traumati...

 122

Single cell lipid biology

Single cell lipid biology

 112

Environmental Risk Factors for Parkinson’s Disease: A Critical Review and Policy Implications

Environmental Risk Factors for Parkinson’s Disease: A C...

 124